Dr. Maisa is the current Dean and previous Vice Dean of the School of Biotechnology at BUC. She has more than 30 years of organic chemistry practice and research experience.

Dr. Maisa received her Bachelor of Science from Assiut University and received her master’s and Ph.D. degrees from the same university. She has received numerous awards for research, teaching, and administrative works.

Moreover, she obtained a post-doctoral fellowship from Aachen, Germany in 2006.

She is serving as a professor of chemistry at the School of Pharmacy BUC from 2015 until now. Also, she is a professor of organic chemistry in the Chemistry Department, at the Faculty of Science, Assiut University.

Dr. Maisa attended and participated in several international and national conferences and presses and has published over 40 publications in organic chemistry.

Dr. Mahmoud Elsabahy is a Professor of Pharmaceutical Technology and Nanomedicine, with more than 15 years of experience in the development of cutting-edge technologies for gene therapy, and delivery of biotechnology-related products.

He is a fellow of the Leaders in Innovation Fellowship Program (Royal Academy Engineering in London) that provided added skills in business and entrepreneurship, a pivotal bridge between academia and industry. He has completed M.Sc. and Ph.D. degrees from the Faculty of Pharmacy, the University of Montreal “Pharmaceutical Nanotechnology” (Montreal, Canada).

Academic experience includes teaching in Egypt and North America and participating in the development of curricula for multiple programs, both at undergraduate and postgraduate levels. He is also the head of the BUC Research Academy, and he is participating in several committees, including the coordinator of World University Rankings at BUC and the secretary of BUC Council of Postgraduate Studies.

Dr. Elsabahy has been the Assistant Director of a research facility at Texas A&M University (Texas, USA, 2011-2020). He is currently a Visiting Scholar at Texas A&M University and the Editor of the Journal of Toxicology.

He has been ranked in 2020 among the Top 2% scientists in the world and the Top 1% scientists in the world in “Pharmacy and Pharmacology”, as named by Stanford University World’s Top 2% Scientists. He contributed to ca. 90 publications, all in international top-profile peer-reviewed journals (e.g., Nature Communications, Nano Letters, Journal of the American Chemical Society, etc.), book chapters, and US patents, and he is the Principal Investigator on several grant applications.

Research interests include the rational design of pharmaceutical dosage forms and nanomedicine for delivery of DNA/RNA-based biotechnology materials and other small molecules, proteins, peptides, antigens, for various therapeutic and diagnostic biomedical applications, for which he has received several national and international prestigious awards. In May 2016, he received the State Award, and in August 2017, he received the Excellence Medal “First Class” from the Egyptian President. His contributions have been highlighted six times in prestigious global journals in the world.

Recently, in 2021, he won the Gold Medal from the International Exhibition of Inventions of Geneva and has been awarded the Obada Prize. He has been participating in the planning and management of science and technology in Egypt through membership in the Egyptian Young Academy of Science. Moreover, he is currently an Ambassador for the Egyptian Young Academy of Science.